Endoscopy 2023; 55(S 02): S40-S41
DOI: 10.1055/s-0043-1765096
Abstracts | ESGE Days 2023
Oral presentation
EUS anastomoses and LAMS – whats new? 20/04/2023, 14:00 – 15:00 Ecocem

Patient profile, procedure technique and clinical outcomes of transjejunal ERCP (TJ-ERC) via EUS-guided entero-anastomosis (EUS-EA) using lumen-apposing metal stents (LAMS) in Roux-en-Y Hepaticojejunostomy (RYHJ)

Authors

  • A. Martinez-Ortega

    1   Rio Hortega University Hospital, Valladolid, Spain
  • R. Mulki

    2   University of Alabama at Birmingham, Birmingham, United States of America
  • R. Kunda

    3   UZ Brussel, Jette, Belgium
  • S. Fernandez Prada

    1   Rio Hortega University Hospital, Valladolid, Spain
  • M. De Benito Sanz

    1   Rio Hortega University Hospital, Valladolid, Spain
  • N. Messaoudi

    3   UZ Brussel, Jette, Belgium
  • A. Y. Carbajo

    1   Rio Hortega University Hospital, Valladolid, Spain
  • R. Sánchez-Ocaña

    1   Rio Hortega University Hospital, Valladolid, Spain
  • C. De La Serna Higuera

    1   Rio Hortega University Hospital, Valladolid, Spain
  • M. Perez-Miranda

    1   Rio Hortega University Hospital, Valladolid, Spain
 

Aims Biliary obstruction(BO) in RYHJ is currently managed percutaneously, particularly when strictures or hepatolithiasis dictate iterative revisions, or adhesions preclude enteroscopy-ERCP. EUS-EA with LAMS could facilitate ERCP in RYHJ. Aim: To assess feasibility, safety and efficacy of EUS-EA-assisted TJ-ERCP in RYHJ patients.

Methods Consecutive patients from 2 centers with BO and RYHJ who underwent TJ-ERCP between 2014-2022 were reviewed. Technical success: TJ-ERCP completion. Short-term clinical success: BO resolution without relapses <30 days. Long-term clinical success: removal of percutaneous biliary drains with no relapses/unplanned reinterventions <365 days ± stricture resolution/stone clearance [1] [2] [3] [4].

Results 73 patients [48(65,75%) male;64(11.71)years]underwent attempted TJ-ERCP. BO was benign in 64(88%). Median time(IQR) between index RYHJ and EUS-EA:7.4(12.03)years. EUS-EA was successful in 69/73 (94.5%). Type of EUS-EA: 39.7% gastro-jejunostomy; 41,1% duodeno-jejunostomy (10, bulb; 20, 2nd duodenum); 19.2% jejuno-jejunostomy. Same-session ERCP in 28/43 (40.6%). AEs: 6/73 (8.5%). 7 LAMS dislodgements (all managed endoscopically). Long-term clinical success: 59/73 (80.8%) (▶[Table 1]).

Zoom
Table 1  Results.

Conclusions EUS-EA assisted TJ-ERCP appears safe and effective. Technical success/patient tolerance appear better than in enteroscopy-ERCP/PTBD, respectively. Underlying disease is more challenging than in EDG. Definitive resolution is achieved in 80.8%. TJ-ERCP might be the primary approach to BO in RYHJ.



Publication History

Article published online:
14 April 2023

© 2023. European Society of Gastrointestinal Endoscopy. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany